{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T02:28:17Z","timestamp":1772504897963,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T00:00:00Z","timestamp":1617321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T00:00:00Z","timestamp":1617321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1038\/s41431-021-00871-4","type":"journal-article","created":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T07:02:34Z","timestamp":1617346954000},"page":"1634-1644","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Stakeholders\u2019 views of integrating universal tumour screening and genetic testing for colorectal and endometrial cancer into routine oncology"],"prefix":"10.1038","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9186-1644","authenticated-orcid":false,"given":"Rosie","family":"O\u2019Shea","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole M.","family":"Rankin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maira","family":"Kentwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Gleeson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine M.","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7558-9794","authenticated-orcid":false,"given":"Heather","family":"Hampel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,2]]},"reference":[{"key":"871_CR1","unstructured":"Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC CancerBase No. 11. Lyon, France: International Agency for Research on Cancer. 2014."},{"key":"871_CR2","unstructured":"Forman D, Bray F, Brewster DH, Gombe Mbalawa C, Kohler B, Pi\u00f1eros M, et al. Cancer incidence in five continents. Vol. X. International Agency for Research on Cancer; 2014."},{"key":"871_CR3","unstructured":"Australian Institute of Health and Welfare (AIHW). Cancer in Australia. Canberra: AIHW; 2017. Cancer series no.101. Cat. no. CAN 100."},{"key":"871_CR4","doi-asserted-by":"publisher","first-page":"18151","DOI":"10.3748\/wjg.v20.i48.18151","volume":"20","author":"H Raskov","year":"2014","unstructured":"Raskov H, Pommergaard HC, Burcharth J, Rosenberg J. Colorectal carcinogenesis-update and perspectives. World J Gastroenterol. 2014;20:18151\u201364.","journal-title":"World J Gastroenterol"},{"key":"871_CR5","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1200\/JCO.2014.58.1322","volume":"33","author":"EM Stoffel","year":"2015","unstructured":"Stoffel EM, Mangu PB, Gruber SB, Hamilton SR, Kalady MF, WanYee Lau M, et al. Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines. J Clin Oncol. 2015;33:209\u201317.","journal-title":"J Clin Oncol"},{"key":"871_CR6","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1200\/JCO.2011.39.5590","volume":"30","author":"AK Win","year":"2012","unstructured":"Win AK, Young JP, Lindor NM, Tucker KM, Ahnen DJ, Young GP, et al. Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study. J Clin Oncol. 2012;30:958\u201364.","journal-title":"J Clin Oncol"},{"key":"871_CR7","doi-asserted-by":"publisher","first-page":"e1003263","DOI":"10.1371\/journal.pmed.1003263","volume":"17","author":"NAJ Ryan","year":"2020","unstructured":"Ryan NAJ, McMahon R, Tobi S, Snowsill T, Esquibel S, Wallace AJ, et al. The proportion of endometrial tumours associated with Lynch syndrome (PETALS): A prospective cross-sectional study. PLoS Med. 2020;17:e1003263.","journal-title":"PLoS Med"},{"key":"871_CR8","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1038\/modpathol.2016.135","volume":"29","author":"KL Ring","year":"2016","unstructured":"Ring KL, Bruegl AS, Allen BA, Elkin EP, Singh N, Hartman AR, et al. Germline multi-gene hereditary cancer panel testing in an unselected endometrial cancer cohort. Mod Pathol. 2016;29:1381\u20139.","journal-title":"Mod Pathol"},{"key":"871_CR9","unstructured":"Medicare benefit schedule. Australian Government Department of Health 2020. Available from http:\/\/www.mbsonline.gov.au\/internet\/mbsonline\/publishing.nsf\/Content\/20200501-News."},{"key":"871_CR10","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1007\/BF02053699","volume":"34","author":"HFA Vasen","year":"1991","unstructured":"Vasen HFA, Mecklin JP, Meera Khan P, Lynch HT. The International Collaborative Group on hereditary nonpolyposis colorectal cancer (ICG-HNPCC). Dis Col Rectum. 1991;34:424\u20135.","journal-title":"Dis Col Rectum"},{"key":"871_CR11","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0016-5085(99)70510-X","volume":"116","author":"HFA Vasen","year":"1999","unstructured":"Vasen HFA, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC. Gastroenterology. 1999;116:1453\u20136.","journal-title":"Gastroenterology"},{"key":"871_CR12","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1093\/jnci\/89.23.1758","volume":"89","author":"MA Rodriguez-Bigas","year":"1997","unstructured":"Rodriguez-Bigas MA, Boland CR, Hamilton SR, Henson DE, Jass JR, Khan PM, et al. A National Cancer Institute workshop on hereditary nonpolyposis colorectal cancer syndrome: meeting highlights and Bethesda Guidelines. J Natl Cancer Inst. 1997;89:1758\u201362.","journal-title":"J Natl Cancer Inst"},{"key":"871_CR13","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/jnci\/djh034","volume":"96","author":"A Umar","year":"2004","unstructured":"Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, R\u00fcschoff J, et al. Revised bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch Syndrome) and microsatellite instability. J Natl Cancer Inst. 2004;96:261\u20138.","journal-title":"J Natl Cancer Inst"},{"key":"871_CR14","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1136\/jmg.37.9.641","volume":"37","author":"S Syngal","year":"2000","unstructured":"Syngal S, Fox EA, Eng C, Kolodner RD, Garber JE. Sensitivity and specificity of clinical criteria for hereditary non-polyposis colorectal cancer associated mutations in MSH2 and MLH1. J Med Genet. 2000;37:641\u20135.","journal-title":"J Med Genet"},{"key":"871_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/GIM.0b013e31818fa2ff","volume":"11","author":"Recommendations from the EGAPP Working Group.","year":"2009","unstructured":"Recommendations from the EGAPP Working Group. genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genet Med. 2009;11:35\u201341.","journal-title":"Genet Med."},{"key":"871_CR16","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/gim.2013.166","volume":"16","author":"M Hegde","year":"2014","unstructured":"Hegde M, Ferber M, Mao R, Samowitz W, Ganguly A. ACMG technical standards and guidelines for genetic testing for inherited colorectal cancer (Lynch syndrome, familial adenomatous polyposis, and MYH-associated polyposis). Genet Med. 2014;16:101\u201316.","journal-title":"Genet Med"},{"key":"871_CR17","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/GIM.0b013e31818fa2db","volume":"11","author":"GE Palomaki","year":"2009","unstructured":"Palomaki GE, McClain MR, Melillo S, Hampel HL, Thibodeau SN. EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome. Genet Med. 2009;11:42\u201365.","journal-title":"Genet Med"},{"key":"871_CR18","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.cgh.2010.03.010","volume":"8","author":"H Singh","year":"2010","unstructured":"Singh H, Schiesser R, Anand G, Richardson P, El- Serag HB. Underdiagnoses of Lynch syndrome involves more than family history criteria. Clin Gastroenterol Hepatol. 2010;8:523\u20139.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"871_CR19","doi-asserted-by":"publisher","unstructured":"Pi S, Nap-Hill E, Telford J, Enns R. Recognition of Lynch syndrome amongst newly diagnosed colorectal cancers at St. Paul\u2019s Hospital. Can J Gastroenterol Hepatol. 2017. https:\/\/doi.org\/10.1155\/2017\/9625638.","DOI":"10.1155\/2017\/9625638"},{"key":"871_CR20","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/jpm4010020","volume":"4","author":"YY Tan","year":"2014","unstructured":"Tan YY, Fitzgerald LJ. Barriers and motivators for referral of patients with suspected Lynch syndrome to cancer genetic services: a qualitative Study. J Pers Med. 2014;4:20\u201334.","journal-title":"J Pers Med."},{"key":"871_CR21","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s10897-011-9401-x","volume":"21","author":"CF Prochniak","year":"2012","unstructured":"Prochniak CF, Martin LJ, Miller EM, Knapke SC. Barriers to and motivations for physician referral of patients to cancer genetics clinics. J Genet Couns. 2012;21:305\u201325.","journal-title":"J Genet Couns"},{"key":"871_CR22","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1053\/j.gastro.2010.02.053","volume":"138","author":"HF Vasen","year":"2010","unstructured":"Vasen HF, Abdirahman M, Brohet R, Langers AM, Kleibeuker JH, van Kouwen M, et al. One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome. Gastroenterology. 2010;138:2300\u20136.","journal-title":"Gastroenterology."},{"key":"871_CR23","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1038\/ajg.2014.186","volume":"109","author":"FM Giardiello","year":"2014","unstructured":"Giardiello FM, Allen JI, Axilbund JE, Boland CR, Burke CA, Burt RW, et al. Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-society Task Force on colorectal cancer. Am J Gastroenterol. 2014;109:1159\u201379.","journal-title":"Am J Gastroenterol"},{"key":"871_CR24","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1056\/NEJMoa043146","volume":"352","author":"H Hampel","year":"2005","unstructured":"Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N. Engl J Med. 2005;352:1851\u201360.","journal-title":"N. Engl J Med"},{"key":"871_CR25","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10689-016-9893-5","volume":"15","author":"H Hampel","year":"2016","unstructured":"Hampel H. Genetic counseling and cascade genetic testing in Lynch syndrome. Fam Cancer. 2016;15:423\u20137.","journal-title":"Fam Cancer"},{"key":"871_CR26","doi-asserted-by":"publisher","first-page":"72","DOI":"10.5694\/mja2.50356","volume":"212","author":"YJ Kang","year":"2020","unstructured":"Kang YJ, Killen J, Caruana M, Simms K, Taylor N, Frayling IM, et al. The predicted impact and cost-effectiveness of systematic testing of people with incident colorectal cancer for Lynch syndrome. Med J Aust. 2020;212:72\u201381.","journal-title":"Med J Aust"},{"key":"871_CR27","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1200\/JCO.2011.38.4719","volume":"30","author":"LC Beamer","year":"2012","unstructured":"Beamer LC, Grant ML, Espenschied CR, Blazer KR, Hamplel HL, Weitzel JN, et al. Reflex immunohistochemistry and microsatellite instability testing of colorectal tumors for Lynch syndrome among US cancer programs and follow-up of abnormal results. J Clin Oncol. 2012;30:1058\u201363.","journal-title":"J Clin Oncol"},{"key":"871_CR28","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1748-5908-4-50","volume":"4","author":"L Damschroder","year":"2009","unstructured":"Damschroder L, Aron D, Keith R, Kirsh S, Alexander J, Lowery J. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4:50.","journal-title":"Implement Sci"},{"key":"871_CR29","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1038\/s41436-020-0838-x","volume":"22","author":"R O\u2019Shea","year":"2020","unstructured":"O\u2019Shea R, Rankin NM, Kentwell M, Gleeson M, Salmon L, Tucker KM, et al. How can Australia integrate routine genetic sequencing in oncology: a qualitative study through an implementation science lens. Genet Med. 2020;22:1507\u201316.","journal-title":"Genet Med"},{"key":"871_CR30","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/gim.2017.39","volume":"19","author":"KM West","year":"2017","unstructured":"West KM, Burke W, Korngiebel DM. Identifying \u201cownership\u201d through role descriptions to support implementing universal colorectal cancer tumor screening for Lynch syndrome. Genet Med. 2017;19:1236\u201344.","journal-title":"Genet Med"},{"key":"871_CR31","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/gim.2015.43","volume":"18","author":"JL Schneider","year":"2016","unstructured":"Schneider JL, Davis J, Kauffman TL, Reiss JA, McGinley C, Arnold K, Zepp J, et al. Stakeholder perspectives on implementing a universal Lynch syndrome screening program: a qualitative study of early barriers and facilitators. Genet Med. 2016;18:152\u201361.","journal-title":"Genet Med"},{"key":"871_CR32","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1245\/s10434-018-6809-7","volume":"26","author":"VN Palter","year":"2019","unstructured":"Palter VN, Baker NA, Pollett A, Daly C, Facey M, Roteberg C, Rabeneck L, Baxter NN. Learning by example: an international perspective on reflex-testing for Lynch Syndrome. Ann Surg Oncol. 2019;26:425\u201336.","journal-title":"Ann Surg Oncol"},{"key":"871_CR33","doi-asserted-by":"publisher","unstructured":"Harris R, Taylor BL, Minor V, Elliott M, Fernandez L, O\u2019Neal L, REDCap consortium et al. The REDCap consortium: building an international community of software partners, J Biomed Inform. 2019. https:\/\/doi.org\/10.1016\/j.jbi.2019.103208.","DOI":"10.1016\/j.jbi.2019.103208"},{"key":"871_CR34","doi-asserted-by":"crossref","unstructured":"Pope C, Mays N. Qualitative research in healthcare. 3rd ed. Oxford, United Kingdom: Blackwell Publishing Ltd; 2006.","DOI":"10.1002\/9780470750841"},{"key":"871_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep29506","volume":"6","author":"A George","year":"2016","unstructured":"George A, Riddell D, Seal S, Talukdar S, Mahamdallie S, Ruark E, et al. Implementing rapid, robust, cost effective, patient-centred, routine genetic testing in ovarian cancer patients. Sci Rep. 2016;6:1\u20138.","journal-title":"Sci Rep."},{"key":"871_CR36","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.ygyno.2018.03.059","volume":"149","author":"D Uyar","year":"2018","unstructured":"Uyar D, Neary J, Monroe A, Nugent M, Simpson P, Geurts JL. Implementing a quality improvement project for universal genetic testing in women with ovarian cancer. Gynecol Oncol. 2018;149:565\u20139.","journal-title":"Gynecol Oncol"},{"key":"871_CR37","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1200\/JCO.2017.76.2781","volume":"36","author":"N Colombo","year":"2018","unstructured":"Colombo N, Huang G, Scambia G, Chalas E, Pignata S, Fiorica J, et al. Evaluation of a streamlined oncologist-Led BRCA mutation testing and counseling model for patients with ovarian cancer. J Clin Oncol. 2018;36:1300\u20137.","journal-title":"J Clin Oncol"},{"key":"871_CR38","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1001\/jamaoncol.2015.5495","volume":"2","author":"BM Norquist","year":"2016","unstructured":"Norquist BM, Harrell MI, Brady MF, Walsh T, Lee MK, Gulsuner S, et al. Inherited mutations in women with ovarian carcinoma. JAMA Oncol. 2016;2:482\u201390.","journal-title":"JAMA Oncol"},{"key":"871_CR39","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1200\/JCO.19.02107","volume":"38","author":"DT Le","year":"2020","unstructured":"Le DT, Kim TW, Van Cutsem E, Geva R, J\u00e4ger D, Hara H, et al. Phase II open-label study of pembrolizumab in treatment-refractory, microsatellite instability-high\/mismatch repair-deficient metastatic colorectal cancer: KEYNOTE-164. J Clin Oncol. 2020;38:11\u201319.","journal-title":"J Clin Oncol"},{"key":"871_CR40","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/S1470-2045(17)30422-9","volume":"18","author":"MJ Overman","year":"2017","unstructured":"Overman MJ, McDermott R, Leach JL, Lonardi S, Lenz HJ, Morse MA, et al. Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an openlabel, multicentre, phase 2 study. Lancet Oncol. 2017;18:1182\u201391.","journal-title":"Lancet Oncol"},{"key":"871_CR41","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1056\/NEJMoa2017699","volume":"383","author":"T Andr\u00e9","year":"2020","unstructured":"Andr\u00e9 T, Shiu KK, Kim TW, Jensen BV, Jensen LH, Punt C. KEYNOTE-177 Investigators et al. Pembrolizumab in microsatellite-instability-high advanced colorectal cancer. N. Engl J Med. 2020;383:2207\u201318.","journal-title":"N. Engl J Med"},{"key":"871_CR42","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41591-020-0805-8","volume":"26","author":"M Chalabi","year":"2020","unstructured":"Chalabi M, Fanchi LF, Dijkstra KK, Van den Berg JG, Aalbers AG, Sikorska K, Lopez-Yurda M, et al. Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers. Nat Med. 2020;26:566\u201376.","journal-title":"Nat Med"},{"key":"871_CR43","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1038\/s41436-020-0785-6","volume":"22","author":"S White","year":"2020","unstructured":"White S, Jacobs C, Phillips J. Mainstreaming genetics and genomics: a systematic review of the barriers and facilitators for nurses and physicians in secondary and tertiary care. Genet Med. 2020;22:1149\u201355.","journal-title":"Genet Med"},{"key":"871_CR44","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1200\/PO.19.00338","volume":"4","author":"JS de Moor","year":"2020","unstructured":"de Moor JS, Gray SW, Mitchell SA, Klabunde CN, Freedman AN. Oncologist confidence in genomic testing and implications for using multimarker tumor panel tests in practice. JCO Precis Oncol. 2020;4:620\u201331.","journal-title":"JCO Precis Oncol."},{"key":"871_CR45","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s10689-019-00122-y","volume":"18","author":"N Hallowell","year":"2019","unstructured":"Hallowell N, Wright S, Stirling D, Gourley C, Young O, Porteous M. Moving into the mainstream: healthcare professionals\u2019 views of implementing treatment focussed genetic testing in breast cancer care. Fam Cancer. 2019;18:293\u2013301.","journal-title":"Fam Cancer"},{"key":"871_CR46","doi-asserted-by":"publisher","unstructured":"Rana HQ, Kipnis L, Hehir K, Cronin A, Jaung T, Stokes SM, Fekrmandi F, et al. Embedding a genetic counselor into oncology clinics improves testing rates and timeliness for women with ovarian cancer. Gynecol Oncol. 2020. https:\/\/doi.org\/10.1016\/j.ygyno.2020.11.003.","DOI":"10.1016\/j.ygyno.2020.11.003"},{"key":"871_CR47","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s10897-013-9603-5","volume":"23","author":"SA Cohen","year":"2014","unstructured":"Cohen SA. Current Lynch syndrome tumor screening practices: a survey of genetic counselors. J Genet Couns. 2014;23:38\u201347.","journal-title":"J Genet Couns"},{"key":"871_CR48","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/gim.2014.31","volume":"16","author":"D Cragun","year":"2014","unstructured":"Cragun D, DeBate RD, Vadaparampil ST, Baldwin J, Hampel H, Pal T. Comparing universal Lynch Syndrome tumor screening programs to evaluate associations between implementation strategies and patient follow through. Genet Med. 2014;16:773\u201382.","journal-title":"Genet Med"},{"key":"871_CR49","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/ajco.13076","volume":"14","author":"L Mascarenhas","year":"2018","unstructured":"Mascarenhas L, Shanley S, Mitchell G, Spurdle A, Macrae F, Pachter N, et al. Current mismatch repair deficiency tumor testing practices and capabilities: a survey of Australian pathology providers. Asia-Pac J Clin Oncol. 2018;14:417\u201325.","journal-title":"Asia-Pac J Clin Oncol"},{"key":"871_CR50","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1136\/gutjnl-2019-319915","volume":"69","author":"KJ Monahan","year":"2020","unstructured":"Monahan KJ, Bradshaw N, Dolwani S, Hereditary CRC. guidelines eDelphi consensus group, et al. Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)\/Association of Coloproctology of Great Britain and Ireland (ACPGBI)\/United Kingdom Cancer Genetics Group (UKCGG). Gut. 2020;69:411\u201344.","journal-title":"Gut"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-021-00871-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-021-00871-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-021-00871-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T00:04:20Z","timestamp":1635811460000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-021-00871-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,2]]},"references-count":50,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["871"],"URL":"https:\/\/doi.org\/10.1038\/s41431-021-00871-4","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,2]]},"assertion":[{"value":"3 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}